Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Tools & Technology » Mass Spec » Waters Reports Preliminary Q2 Revenue Drop of 13 to 14 Percent, Names New CEO

Waters Reports Preliminary Q2 Revenue Drop of 13 to 14 Percent, Names New CEO

Jul 15, 2020
|
staff reporter

NEW YORK – Waters said on Wednesday that it expects Q2 2020 revenues of between $517 million and $523 million, down 13 percent to 14 percent from $599 million in Q2 2019 but above the consensus Wall Street estimate of $485.4 million.

The Milford, Massachusetts-based company also announced that it has named Udit Batra as president and CEO, effective Sept. 1, 2020. Batra, who was previously CEO of MilliporeSigma, the life sciences arm of Merck, will succeed Christopher O'Connell.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Funds Sought for Vaccine Distribution

The Washington Post reports that US states and territories are seeking more funding for the distribution of SARS-CoV-2 vaccines.

Virus Variant From Spain Now Across UK

The strain now accounts for about 80 percent of cases in Wales and Scotland, and about half of cases in England, the Guardian reports.

Unexpected Loss

A new study suggests that using CRISPR to edit human embryonic DNA can lead to the loss of whole chromosomes, as the Associated Press reports.

Science Papers on Long Human-Canine Relationship, Population History of Early East Asians, More

In Science this week: ancient dog genomes highlight long ties with humans, genomic analysis of 40,000-year-old early East Asian individual, and more.

Nov
17
Featured Webinar

Spatial Expression Analyses Elucidates Mechanisms of circRNAs in Cancer

Sponsored by
ACD

Circular RNAs (circRNAs) have recently gained substantial attention in the cancer research field where most, including the putative oncogene ciRS-7 (CDR1as), have been proposed to function as competitive endogenous RNAs (ceRNAs) by “sponging” specific microRNAs.

What's Popular?

In Proteomics & Protein Research

  1. COVID-19 Multiomic Immune Response Study Reveals Differences in Disease Progression, Severity

  2. Biodesix Prices $72M IPO

  3. SomaLogic Partners With FDA to Test Proteomic Tech for Evaluating Biosimilars

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.